3
Announcements
Trials
Browse
Landscape
Status
Completed
7
Recruiting
6
Withdrawn
2
Unknown
2
Terminated
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
CNS
1
Conditions
Lung Neoplasms
2
Stomach Neoplasms
1
Pathologic Complete Response
1
Head and Neck Neoplasms
1
Glioma
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Radiotherapy
4
aflutinib
3
Saline Solution
3
Radiosurgery
3
pembrolizumab
2
Temozolomide
2
Receptors, Interleukin-8B
2
Pemetrexed
2
Memantine
2
Magnetic Resonance Spectroscopy
2
Indocyanine Green
2
Dexmedetomidine
2
Cyclophosphamide
2
Carboplatin
2
Blood Specimen Collection
2
Bevacizumab
2
vorasidenib
1
urinastatin
1
trastuzumab deruxtecan
1
tovorafenib
1
sacituzumab govitecan
1
posaconazole
1
peginterferon alfa-2b
1
osimertinib
1
neratinib
1
montelukast
1
gallium maltolate
1
fludarabine
1
dalpiciclib
1
asciminib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Brain Neoplasms
×
Magnetic Resonance Imaging
×
Clear all
NCT07185958
2025-09-22
DART
Aalborg University Hospital
Not yet recruiting
80 enrolled